ABBISKO-B

2256
6.4205.45% ( -0.370 )
Delay Closed: Nov 16, 16:08:11

Shareholders

All Shareholders

Shareholder Type

  • Public and others30.16%
  • Institutions29.26%
  • Individuals & Insiders17.29%
  • VC/PE firms12.39%
  • Others10.91%

Major Shareholders

Major Shareholders Latest
Shareholder
Yao-Chang XuFounder, Executive Chairman of the Board & CEO
12.11%80.22M0.93%+145.00K
GIC Private Limited
7.69%50.95M1.58%+7.19M
Allianz Asset Management GmbH
7.68%50.86M1.99%+10.17M
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
6.21%41.14M0.16%+357.46K
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
6.18%40.91M0.10%+0
The Goldman Sachs Group, Inc.
4.12%27.29M0.07%+0
Norges Bank Investment Management
3.40%22.54M0.87%+5.49M
Vanguard Capital Management, LLC
3.20%21.22M0.27%+194.00K
Zhui ChenCo-Founder, Former Senior VP of Biology, Chief Scientific Officer & Executive Director
2.60%17.21M0.04%+0
Hongping YuCo-Founder, SVP of Chemistry, Chief Scientific Officer & Executive Director
2.58%17.07M0.19%+0
Abbisko Glorious Ode Trust
2.36%15.60M0.02%-137.50K
FMR LLC
2.26%14.94M0.61%+3.14M
Value Partners Hong Kong Limited
1.62%10.73M0.21%+1.22M
Morgan Stanley
1.57%10.38M0.03%+0
BlackRock, Inc.
1.29%8.53M0.15%+414.00K
OrbiMed Advisors LLC
0.66%4.36M0.01%+0
Abbisko Galaxy Myth Limited
0.53%3.49M0.02%-164.80K
Dacheng Fund Management Co., Ltd.
0.48%3.21M<0.01%+0
Neuberger Berman Investment Advisers LLC
0.45%3.00M<0.01%+0
Franklin Templeton Sealand Fund Management Co., Ltd.
0.44%2.89M<0.01%+0